Novartis Balance Sheet Health
Financial Health criteria checks 4/6
Novartis has a total shareholder equity of $39.8B and total debt of $25.5B, which brings its debt-to-equity ratio to 64.2%. Its total assets and total liabilities are $94.3B and $54.6B respectively. Novartis's EBIT is $14.3B making its interest coverage ratio 57.4. It has cash and short-term investments of $9.6B.
Key information
64.2%
Debt to equity ratio
US$25.53b
Debt
Interest coverage ratio | 57.4x |
Cash | US$9.65b |
Equity | US$39.76b |
Total liabilities | US$54.58b |
Total assets | US$94.33b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NVSE.F's short term assets ($26.4B) do not cover its short term liabilities ($29.3B).
Long Term Liabilities: NVSE.F's short term assets ($26.4B) exceed its long term liabilities ($25.3B).
Debt to Equity History and Analysis
Debt Level: NVSE.F's net debt to equity ratio (40%) is considered satisfactory.
Reducing Debt: NVSE.F's debt to equity ratio has increased from 60.6% to 64.2% over the past 5 years.
Debt Coverage: NVSE.F's debt is well covered by operating cash flow (53.9%).
Interest Coverage: NVSE.F's interest payments on its debt are well covered by EBIT (57.4x coverage).